COPD mortality risk minimized by corticosteroidsAccording to a new study that was published in an issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), chronic obstructive pulmonary disease (COPD) patients using inhaled corticosteroids are likely to have a considerably reduced mortality risk.

It was revealed by the researchers that patients receiving inhaled corticosteroids within a period of 30 days of hospital discharge had a 25 percent reduced all-cause mortality rate. It was also noted that patients using steroids paired with beta-agonists saw a fall in cardiovascular-related deaths by 38 percent.

Author Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada, said that COPD is an underrated lung ailment that has associated lung disease.